The Latest Breaking News from Quadri Pharma

Here's Why Jaguar Health Shares Are Rising

Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 10.90% at $0.70 on continued momentum after the company last week announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Mid

Benzinga · Apr 4, 2022

Here's Why Jaguar Health Shares Are Popping Off

Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 31.2% at $0.70 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East.

Benzinga · Mar 31, 2022